Up-front temozolomide in elderly patients with glioblastoma

[1]  A. Brandes,et al.  Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma , 2009, Cancer.

[2]  S. Franceschi,et al.  Age as a Predictive Factor in Glioblastomas: Population-Based Study , 2009, Neuroepidemiology.

[3]  S. Taillibert,et al.  Short course of radiation therapy in elderly patients with glioblastoma multiforme. , 2008, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[4]  A. Sloan,et al.  Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma. , 2008, Journal of neurosurgery.

[5]  J. Debus,et al.  Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. , 2008, International journal of radiation oncology, biology, physics.

[6]  Pierre-Marie Martin,et al.  Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Luc Taillandier,et al.  Radiotherapy for glioblastoma in the elderly. , 2007, The New England journal of medicine.

[8]  M. Chamberlain,et al.  A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastoma , 2007, Journal of Neuro-Oncology.

[9]  K. Hoang-Xuan,et al.  MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities , 2007, Journal of Neuro-Oncology.

[10]  M. Wolter,et al.  Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors , 2005, International journal of cancer.

[11]  K. Hoang-Xuan,et al.  Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations , 2004, Cancer.

[12]  E. Bruera,et al.  Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  L. Recht,et al.  Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas , 2003, Cancer.

[14]  Y. Katayama,et al.  Promoter Hypermethylation of the DNA Repair Gene O6‐Methylguanine‐DNA Methyltransferase is an Independent Predictor of Shortened Progression Free Survival in Patients with Low‐grade Diffuse Astrocytomas , 2003, Brain pathology.

[15]  P Schaffer,et al.  Descriptive epidemiology of cerebral gliomas in France , 1997, Cancer.

[16]  T. Cascino,et al.  Response criteria for phase II studies of supratentorial malignant glioma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  G. Beldi,et al.  A prospective, randomized clinical trial , 2004 .